Erenumab efficacy in highly resistant chronic migraine: a real-life study
暂无分享，去创建一个
P. Cortelli | G. Pierangeli | Umberto Pensato | S. Cevoli | V. Favoni | Gian Maria Asioli | E. Merli | Matteo Benini | A. Pascazio | C. Calabrò
[1] S. Sacco,et al. European headache federation consensus on the definition of resistant and refractory migraine , 2020, The Journal of Headache and Pain.
[2] A. Tessitore,et al. Multidimensional assessment of the effects of erenumab in chronic migraine patients with previous unsuccessful preventive treatments: a comprehensive real-world experience , 2020, The Journal of Headache and Pain.
[3] A. Andreou,et al. A prospective real-world analysis of erenumab in refractory chronic migraine , 2020, The Journal of Headache and Pain.